Literature DB >> 15464997

High ER stress in beta-cells stimulates intracellular degradation of misfolded insulin.

Jenny R Allen1, Linh X Nguyen, Karen E G Sargent, Kathryn L Lipson, Anthony Hackett, Fumihiko Urano.   

Abstract

Endoplasmic reticulum (ER) stress, which is caused by the accumulation of misfolded proteins in the ER, elicits an adaptive response, the unfolded protein response (UPR). One component of the UPR, the endoplasmic reticulum-associated protein degradation (ERAD) system, has an important function in the survival of ER stressed cells. Here, we show that HRD1, a component of the ERAD system, is upregulated in pancreatic islets of the Akita diabetes mouse model and enhances intracellular degradation of misfolded insulin. High ER stress in beta-cells stimulated mutant insulin degradation through HRD1 to protect beta-cells from ER stress and ensuing death. If HRD1 serves the same function in humans, it may serve as a target for therapeutic intervention in diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15464997     DOI: 10.1016/j.bbrc.2004.09.035

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

Review 1.  The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology.

Authors:  Christopher J Guerriero; Jeffrey L Brodsky
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

Review 2.  Proinsulin misfolding and diabetes: mutant INS gene-induced diabetes of youth.

Authors:  Ming Liu; Israel Hodish; Leena Haataja; Roberto Lara-Lemus; Gautam Rajpal; Jordan Wright; Peter Arvan
Journal:  Trends Endocrinol Metab       Date:  2010-08-18       Impact factor: 12.015

3.  A TRPV1-to-secretagogin regulatory axis controls pancreatic β-cell survival by modulating protein turnover.

Authors:  Katarzyna Malenczyk; Fatima Girach; Edit Szodorai; Petter Storm; Åsa Segerstolpe; Giuseppe Tortoriello; Robert Schnell; Jan Mulder; Roman A Romanov; Erzsébet Borók; Fabiana Piscitelli; Vincenzo Di Marzo; Gábor Szabó; Rickard Sandberg; Stefan Kubicek; Gert Lubec; Tomas Hökfelt; Ludwig Wagner; Leif Groop; Tibor Harkany
Journal:  EMBO J       Date:  2017-06-21       Impact factor: 11.598

Review 4.  Is insulin signaling molecules misguided in diabetes for ubiquitin-proteasome mediated degradation?

Authors:  Muthuswamy Balasubramanyam; Rangasamy Sampathkumar; Viswanathan Mohan
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

5.  Expression of mutant Ins2C96Y results in enhanced tubule formation causing enlargement of pre-Golgi intermediates of CHO cells.

Authors:  Jing-Yu Fan; Jürgen Roth; Christian Zuber
Journal:  Histochem Cell Biol       Date:  2007-07-24       Impact factor: 4.304

6.  Cells Deploy a Two-Pronged Strategy to Rectify Misfolded Proinsulin Aggregates.

Authors:  Corey N Cunningham; Jeffrey M Williams; Jeffrey Knupp; Anoop Arunagiri; Peter Arvan; Billy Tsai
Journal:  Mol Cell       Date:  2019-06-05       Impact factor: 17.970

7.  Measuring ER stress and the unfolded protein response using mammalian tissue culture system.

Authors:  Christine M Oslowski; Fumihiko Urano
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

8.  PERK (EIF2AK3) regulates proinsulin trafficking and quality control in the secretory pathway.

Authors:  Sounak Gupta; Barbara McGrath; Douglas R Cavener
Journal:  Diabetes       Date:  2010-06-08       Impact factor: 9.461

Review 9.  Misfolded proinsulin in the endoplasmic reticulum during development of beta cell failure in diabetes.

Authors:  Anoop Arunagiri; Leena Haataja; Corey N Cunningham; Neha Shrestha; Billy Tsai; Ling Qi; Ming Liu; Peter Arvan
Journal:  Ann N Y Acad Sci       Date:  2018-01-28       Impact factor: 5.691

10.  Proinsulin maturation, misfolding, and proteotoxicity.

Authors:  Ming Liu; Israel Hodish; Christopher J Rhodes; Peter Arvan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.